ng-nitroarginine methyl ester has been researched along with Invasiveness, Neoplasm in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Guo, ZT; Huang, Q; Li, P; Pan, WK | 1 |
| Benner, A; Berthel, A; Brand, K; Buechler, MW; Falk, CS; Grabe, N; Halama, N; Herrmann, T; Jaeger, D; Kahlert, C; Klupp, F; Koch, M; Krauss, J; Kunz, C; Lasitschka, F; Lerchl, T; Luckner-Minden, C; Luecke, S; Schneider, M; Springfeld, C; Suarez-Carmona, M; Suetterlin, T; Ulrich, A; Weitz, J; Zitvogel, L; Zoernig, I | 1 |
| Kodama, R; Nakahara, M; Nakamura, Y; Sanke, T; Tsujimoto, M; Yasuoka, H; Yoshidome, K | 1 |
| Chakraborty, C; Jadeski, LC; Lala, PK | 1 |
| Dong, XS; Sun, WZ; Yang, Y; Yu, LB; Zhao, DL | 1 |
| Matsui, H; Tsuji, H; Yudoh, K | 1 |
| Bechberger, J; Billiar, TR; Green, AM; Lala, PK; Orucevic, A; Shapiro, RA | 1 |
| Chakraborty, C; Hum, KO; Jadeski, LC; Lala, PK | 1 |
8 other study(ies) available for ng-nitroarginine methyl ester and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Chromones; Cinnamates; Cyclin A2; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p21; Endothelial Cells; Hemangioma; Humans; Infant; Infant, Newborn; Morpholines; Neoplasm Invasiveness; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Norepinephrine; Pericytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proliferating Cell Nuclear Antigen; Propranolol; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Topics: Adenocarcinoma; Apoptosis; Chemokine CCL5; Chemokines; Chemotaxis; Clinical Trials, Phase I as Topic; Clodronic Acid; Colorectal Neoplasms; Cyclohexanes; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Maraviroc; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Phenylurea Compounds; Pilot Projects; Pyridines; Receptors, CCR5; STAT3 Transcription Factor; Survival Analysis; Triazoles; Tumor Cells, Cultured; Tumor Microenvironment | 2016 |
Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.
Topics: Adult; Aged; Aged, 80 and over; Alkenes; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prognosis; Receptors, CXCR4; Tyrosine | 2008 |
Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Topics: Animals; Apoptosis; Cell Cycle; Cell Movement; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Tumor Cells, Cultured | 2003 |
Effect of a nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on invasion of human colorectal cancer cell line SL-174T.
Topics: Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Male; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Tissue Inhibitor of Metalloproteinase-2 | 2005 |
Nitric oxide induced by tumor cells activates tumor cell adhesion to endothelial cells and permeability of the endothelium in vitro.
Topics: Capillary Permeability; Cell Adhesion; Culture Media, Conditioned; E-Selectin; Endothelium, Vascular; Fibrosarcoma; Humans; Integrin alpha4beta1; Integrins; Lewis X Antigen; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Lymphocyte Homing; Tumor Cells, Cultured | 1997 |
Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness.
Topics: Adenocarcinoma; Animals; Enzyme Induction; Female; Gene Expression Regulation, Neoplastic; Interferon-gamma; Lipopolysaccharides; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Recombinant Proteins; Tissue Inhibitor of Metalloproteinase-3; Tumor Cells, Cultured | 1999 |
Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Division; Cell Movement; Enzyme Inhibitors; Female; Immunohistochemistry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Tumor Cells, Cultured | 2000 |